Auntea Jenny Announces 2026 Interim Results 
Xunce 2026 Interim Results: Revenue Up 389%, Net profit of nearly 100 million yuan, Token Revenue Emerges as a New Growth Engine 
Aitenders Technologies Inc. (Formerly, eXeBlock Technology Corporation) Announces Closing of Reverse Takeover with Aitenders and Receipt of Conditional Listing Approval from the Canadian Securities Exchange 
New Manitoba Bonus Prize Clue Released for The Great Canadian Treasure Hunt 
GetHookd Releases API & MCP Server for AI-Powered Ecommerce Ad Research Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS(1) at CER
Paris, April 28, 2021 Sanofi continued its growth trajectory. Strong increase in Q1 2021 business…
Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people
Cardiovascular diseases are responsible for 17.9 million deaths every year¹, a third of all deaths…
argenx Management to Present at Upcoming Virtual Investor Conferences
April 28, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
Santhera and ReveraGen Announce New 2.5-year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy
Pratteln, Switzerland, April 28, 2021 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen Biopharma announce new clinical…
Hyloris Announces Major Commercial Partnership in the U.S. for Maxigesic® IV
Hikma Pharmaceuticals, a leading supplier of complex, injectable hospital products in the U.S., to commercialise…
Innate Pharma Files its 2020 Universal Registration Document (Document d’Enregistrement Universel) and 2020 Annual Report on Form 20-F
Marseille, France, April 28, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH –…
Innate Pharma Files Its 2020 Universal Registration Document (Document D’enregistrement Universel) and 2020 Annual Report on Form 20-F
MARSEILLE, France, April 28, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH –…
CMS Proposes Additional Payment for Shockwave’s Coronary IVL in Hospital Inpatient Cases
New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 Rule SANTA CLARA, CALIF.,…
US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for PD-L1-positive, metastatic triple-negative breast cancer
Basel, 28 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the…
Supernus to Host First Quarter 2021 Financial Results Conference Call
ROCKVILLE, Md., April 27, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
COMPASS Pathways launches proposed public offering
London, UK, April 27, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a…
AnPac Bio to Report Fiscal Year 2020 Financial Results on Friday, April 30, 2021
Earnings Call Scheduled for 8:30 am ET on April 30, 2021 SAN JOSE, Calif., April…
Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021
— Fusogen platform demonstrates potential for cell-specific in vivo delivery of gene therapies to multiple…
Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative…
Krystal Biotech Announces Virtual Presentation of Data from its Vector-Encoded-Antibody Platform at ASGCT
PITTSBURGH, April 27, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
Intellia Therapeutics Announces Presentations at the 24th American Society of Gene and Cell Therapy Annual Meeting
– Updated preclinical data will be presented on CRISPR/Cas9-mediated targeted gene insertion to treat alpha-1…
New Preclinical Data from Dyne Therapeutics’ Myotonic Dystrophy Type 1 Program to be Featured in Presentations During Upcoming American Society of Gene & Cell Therapy Annual Meeting
Company to host webcast including leading DM1 expert, Dr. Charles Thornton, following presentations on May…
Freeline to Present Data at the American Society of Gene and Cell Therapy Annual Meeting 2021
LONDON, April 27, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company”…
4D Molecular Therapeutics Announces Preclinical Data Presentations at ASGCT and ATS Annual Meetings on Three Wholly-Owned Product Candidates from Non-Human Primate Studies
– Abstracts on 4D-150 for wet AMD/DME and 4D-310 for Fabry disease accepted for oral presentations…
Akouos to Present Nonclinical Data from AK-OTOF and AK-antiVEGF Programs at the American Society of Gene and Cell Therapy 24th Annual Meeting
BOSTON, April 27, 2021 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine…